Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Health In Tech, Inc.HIT · Entity 7078 | Chief AI & Marketing Officer | September 24, 2025 | September 26, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Health In Tech, Inc.
Report date September 24, 2025 · Filed September 26, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 64,000 |
Reported balance
After 2025-09-24 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-09-24 · Grant · Acquired 50,000 · Balance 64,000 F1: Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. One third (1/3) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date a letter of intent or memorandum of understanding is signed in connection with an initiative being developed by the Company (the "Initiative"), one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date the Initiative enters proof-of-concept or beta launch, and, the remaining one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date of full commercial launch of the Initiative. F2: Includes 50,000 shares of restricted stock and 14,000 unrestricted shares of Class A Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. One third (1/3) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date a letter of intent or memorandum of understanding is signed in connection with an initiative being developed by the Company (the "Initiative"), one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date the Initiative enters proof-of-concept or beta launch, and, the remaining one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date of full commercial launch of the Initiative.
F2: Includes 50,000 shares of restricted stock and 14,000 unrestricted shares of Class A Common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 24, 2025 Filed Sep 26, 2025 23:20 UTC | Health In Tech, Inc. HIT · Entity 7078 | GrantClass A Common Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-092541 · ownership.xml · nonDerivative · entry 1 Plantholt Dustin · CIK 0002062449 · Chief AI & Marketing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,000 F1 · shares: Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. One third (1/3) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date a letter of intent or memorandum of understanding is signed in connection with an initiative being developed by the Company (the "Initiative"), one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date the Initiative enters proof-of-concept or beta launch, and, the remaining one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date of full commercial launch of the Initiative. F2 · balance_after: Includes 50,000 shares of restricted stock and 14,000 unrestricted shares of Class A Common Stock. Read SEC document |
| March 25, 2025 Filed Mar 27, 2025 20:31 UTC | Health In Tech, Inc. HIT · Entity 7078 | GrantClass A Common Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001013762-25-003408 · ownership.xml · nonDerivative · entry 1 Plantholt Dustin · CIK 0002062449 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 F1 · shares: Represent unrestricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.